Open original FDA record ↗Recall record
- FDA identifier
- Z-2093-2016
- Company in FDA record
- Smith & Nephew, Inc.
- FDA record creation date
- Jun 29, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The surface inside of the femoral component, where cement is applied for adhesion, is below specification.
Source facts
- Action
- The firm sent an Urgent Product Recall letter dated May 26, 2016 to customers, via email and FedEx Overnight delivery . The letter identified the affected product, problem and actions to be taken. Customers were instructed to 1. Inspect inventory and locate any unused devices from the listed product and batch numbers, and quarantine them immediately. 2. Complete the Inventory Return Certification Form on the following page, indicating the quantities that need to be returned. If you do not have product to return, place an x in the column No Product to Return. Include your contact information in the spaces provided at the bottom of the form. 3. Contact Smith & Nephews Field Actions Department via email at FieldActions@smith-nephew.com or fax +1-901-566-7975 to return the completed Inventory Return Certification Form and obtain a return authorization (RA) number if you have product to return. 4. Return any affected product to the address listed on the Inventory Return Certification Form. Indicate the RA number on your return shipment.
- Initiated
- 2016-05-26
- Root cause
- Process control
- Terminated
- 2019-08-16
- Distribution
- Worldwide Distribution and US Nationwide including Puerto Rico and the countries of Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Sweden, and UK.
- Recall number
- Z-2093-2016
- Recall status
- Terminated
- CDRH record ID
- 147037
- FDA record created
- 2016-06-29
- Recall event number
- 74271